Total Payments
$6,458
2024 Payments
$2,225
Companies
21
Transactions
117
Medicare Patients
455
Medicare Billing
$25,150
Payment Breakdown by Category
Food & Beverage$6,111 (94.6%)
Education$346.89 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,111 | 113 | 94.6% |
| Education | $346.89 | 4 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,091 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,009 | 17 | $0 (2024) |
| Amgen Inc. | $705.14 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $657.15 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $405.67 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $341.92 | 3 | $0 (2024) |
| ABBVIE INC. | $332.27 | 14 | $0 (2024) |
| Incyte Corporation | $315.85 | 7 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $305.81 | 3 | $0 (2024) |
| PFIZER INC. | $280.97 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,225 | 42 | Galderma Laboratories, L.P. ($496.44) |
| 2023 | $2,360 | 45 | E.R. Squibb & Sons, L.L.C. ($599.85) |
| 2022 | $1,021 | 16 | Amgen Inc. ($326.07) |
| 2021 | $852.17 | 14 | Ortho Dermatologics, a division of Bausch Health US, LLC ($172.85) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $114.05 | General |
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $6.40 | General |
| 10/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Podiatry | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $123.50 | General |
| Category: Immunology | ||||||
| 09/11/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Inflammation & Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.38 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 08/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Immunology | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $42.50 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 191 | 356 | $25,221 | $11,476 |
| 2022 | 4 | 63 | 127 | $6,863 | $2,867 |
| 2021 | 1 | 12 | 12 | $1,487 | $794.36 |
| 2020 | 7 | 189 | 399 | $22,378 | $10,014 |
Total Patients
455
Total Services
894
Medicare Billing
$25,150
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 81 | $9,827 | $4,599 | 46.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 32 | 36 | $5,464 | $2,535 | 46.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 24 | 25 | $3,407 | $1,417 | 41.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 28 | 34 | $3,078 | $1,159 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,002 | $997.52 | 49.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 26 | 167 | $1,443 | $768.53 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 24 | $2,961 | $1,453 | 49.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 14 | 14 | $1,949 | $765.75 | 39.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 13 | 14 | $1,293 | $346.54 | 26.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 13 | 75 | $660.75 | $301.24 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,487 | $794.36 | 53.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 58 | $5,922 | $2,897 | 48.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 27 | 30 | $4,089 | $1,723 | 42.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 20 | 21 | $3,180 | $1,590 | 50.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 34 | 42 | $3,742 | $1,231 | 32.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $2,806 | $1,171 | 41.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 30 | 216 | $1,690 | $889.28 | 52.6% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 11 | 13 | $948.59 | $511.50 | 53.9% |
About Rene Valiente, MHS, PA-C
Rene Valiente, MHS, PA-C is a Medical healthcare provider based in Coconut Grove, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003965302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rene Valiente, MHS, PA-C has received a total of $6,458 in payments from pharmaceutical and medical device companies, with $2,225 received in 2024. These payments were reported across 117 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,111).
As a Medicare-enrolled provider, Valiente has provided services to 455 Medicare beneficiaries, totaling 894 services with total Medicare billing of $25,150. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Coconut Grove, FL
- Active Since 01/09/2007
- Last Updated 10/14/2025
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1003965302
Products in Payments
- TREMFYA (Drug) $1,432
- Sotyktu (Drug) $991.82
- Otezla (Drug) $705.14
- DUPIXENT (Biological) $495.18
- OPZELURA (Drug) $227.46
- CIBINQO (Drug) $211.28
- SKYRIZI (Biological) $190.14
- AKLIEF (Drug) $171.48
- Zoryve (Drug) $165.74
- ADBRY (Biological) $164.02
- RINVOQ (Biological) $142.13
- VTAMA (Drug) $123.29
- Winlevi (Drug) $121.87
- DUOBRII (Drug) $87.49
- ARAZLO (Drug) $85.36
- EUCRISA (Drug) $69.69
- TALTZ (Drug) $57.05
- JUBLIA (Drug) $39.81
- ZILXI (Drug) $25.26
- ILUMYA (Biological) $23.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.